{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T13:53:59Z","timestamp":1793627639245,"version":"4.5.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","europeanneuropsychopharmacology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.euroneuro.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T08:15:26Z","timestamp":1469261726000},"page":"1475-1483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression"],"prefix":"10.1016","volume":"26","author":[{"given":"Kristi","family":"Pettai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Tammiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urmo","family":"V\u00f5sa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raivo","family":"Kolde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triin","family":"Eller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Metspalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Maron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2016.06.007_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2004.10.047","article-title":"Fluoxetine-induced up-regulation of 14-3-3zeta and tryptophan hydroxylase levels in RBL-2H3 cells","volume":"374","author":"Baik","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2016.06.007_bib2","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1038\/tp.2012.112","article-title":"Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode","volume":"2","author":"Belzeaux","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jad.2014.09.020","article-title":"Risk factors for treatment resistance in unipolar depression: a systematic review","volume":"171","author":"Bennabi","year":"2015","journal-title":"J. Affect. Disord."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11920-008-0042-1","article-title":"Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications","volume":"10","author":"Bruce","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"issue":"5","key":"10.1016\/j.euroneuro.2016.06.007_bib5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.euroneuro.2016.06.007_bib6","first-page":"638","article-title":"The role of IL-2 and soluble IL-2R in depression and antidepressant response","volume":"10","author":"Eller","year":"2009","journal-title":"Curr. Opin. Investig. Drugs"},{"issue":"6","key":"10.1016\/j.euroneuro.2016.06.007_bib7","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1471-4159.2008.05581.x","article-title":"A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice","volume":"106","author":"Galeotti","year":"2008","journal-title":"J. Neurochem."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.06.007_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00406-005-0578-6","article-title":"Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients","volume":"255","author":"Gonul","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib9","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/npp.2014.226","article-title":"Testing the predictive value of peripheral gene expression for nonremission following citalopram treatment for major depression","volume":"40","author":"Guilloux","year":"2015","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archpsyc.64.2.193","article-title":"Reduced prefrontal glutamate\/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy","volume":"64","author":"Hasler","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1741-7015-11-28","article-title":"Depression pathogenesis and treatment: what can we learn from blood mRNA expression?","volume":"11","author":"Hepgul","year":"2013","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.euroneuro.2016.06.007_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"issue":"7","key":"10.1016\/j.euroneuro.2016.06.007_bib13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.20262","article-title":"Role of GABA in anxiety and depression","volume":"24","author":"Kalueff","year":"2007","journal-title":"Depress Anxiety"},{"issue":"4","key":"10.1016\/j.euroneuro.2016.06.007_bib14","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000123041","article-title":"FKBP family proteins: immunophilins with versatile biological functions","volume":"16","author":"Kang","year":"2008","journal-title":"Neurosignals"},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib16","first-page":"122","article-title":"Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis","volume":"31","author":"Kennedy","year":"2006","journal-title":"J. Psychiatry Neurosci.: JPN"},{"issue":"23","key":"10.1016\/j.euroneuro.2016.06.007_bib17","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","article-title":"The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)","volume":"289","author":"Kessler","year":"2003","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.npp.1300353","article-title":"Diminished GABA(A) receptor-binding capacity and a DNA base substitution in a patient with treatment-resistant depression and anxiety","volume":"29","author":"Kosel","year":"2004","journal-title":"Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol."},{"issue":"1","key":"10.1016\/j.euroneuro.2016.06.007_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2013\/984845","article-title":"Biomarkers predicting antidepressant treatment response: how can we advance the field?","volume":"35","author":"Labermaier","year":"2013","journal-title":"Dis. Markers"},{"issue":"8","key":"10.1016\/j.euroneuro.2016.06.007_bib20","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1176\/appi.ajp.2010.09091380","article-title":"Genome-wide association study of major recurrent depression in the U.K. population","volume":"167","author":"Lewis","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib21","article-title":"Genome-wide microarray analysis of gene expression profiling in major depression and antidepressant therapy","author":"Lin","year":"2015","journal-title":"Progress. Neuro-Psychopharmacol. Biol. psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2016.06.007_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1080\/09540260701563460","article-title":"Genomics and the future of pharmacotherapy in psychiatry","volume":"19","author":"Malhotra","year":"2007","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib23","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/tp.2011.12","article-title":"Gene expression biomarkers of response to citalopram treatment in major depressive disorder","volume":"1","author":"Mamdani","year":"2011","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2016.06.007_bib24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ajmg.b.30898","article-title":"Peripheral gene expression profiling of CCK-4-induced panic in healthy subjects","volume":"153B","author":"Maron","year":"2010","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.06.007_bib25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.euroneuro.2009.01.010","article-title":"Serotonin transporter promoter region polymorphisms do not influence treatment response to escitalopram in patients with major depression","volume":"19","author":"Maron","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2016.06.007_bib26","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","article-title":"Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine","volume":"43","author":"Matrisciano","year":"2009","journal-title":"J Psychiatr. Res"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib28","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1471-2164-11-96","article-title":"Variability of gene expression profiles in human blood and lymphoblastoid cell lines","volume":"11","author":"Min","year":"2010","journal-title":"BMC Genom."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1017\/S1461145705005766","article-title":"Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions","volume":"9","author":"Molteni","year":"2006","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/JCP.0000000000000099","article-title":"Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study","volume":"34","author":"Mrazek","year":"2014","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.euroneuro.2016.06.007_bib31","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","article-title":"The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression","volume":"12","author":"Muller","year":"2007","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.euroneuro.2016.06.007_bib32","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.neuron.2009.08.023","article-title":"Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin","volume":"63","author":"Poulopoulos","year":"2009","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.euroneuro.2016.06.007_bib33","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2199-7-3","article-title":"The RIN: an RNA integrity number for assigning integrity values to RNA measurements","volume":"7","author":"Schroeder","year":"2006","journal-title":"BMC Mol. Biol."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.06.007_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","article-title":"Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications","volume":"64","author":"Sen","year":"2008","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.euroneuro.2016.06.007_bib36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14737175.8.1.111","article-title":"The serotonin transporter gene and effectiveness of SSRIs","volume":"8","author":"Serretti","year":"2008","journal-title":"Expert Rev. Neurother."},{"issue":"3","key":"10.1016\/j.euroneuro.2016.06.007_bib37","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajmg.b.30272","article-title":"Evaluating the comparability of gene expression in blood and brain","volume":"141B","author":"Sullivan","year":"2006","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatr. Genet.: Off. Publ. Int. Soc. Psychiatr. Genet."},{"issue":"12","key":"10.1016\/j.euroneuro.2016.06.007_bib38","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"Trivedi","year":"2006","journal-title":"New Engl. J. Med."},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.socscimed.2010.03.035","article-title":"Gender differences in depression in 23 European countries. Cross-national variation in the gender gap in depression","volume":"71","author":"Van de Velde","year":"2010","journal-title":"Soc. Sci. Med"},{"issue":"2","key":"10.1016\/j.euroneuro.2016.06.007_bib40","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/070674370204700208","article-title":"Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine","volume":"47","author":"Vanderkooy","year":"2002","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"issue":"6","key":"10.1016\/j.euroneuro.2016.06.007_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.neuron.2006.09.003","article-title":"Neuroligins determine synapse maturation and function","volume":"51","author":"Varoqueaux","year":"2006","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.euroneuro.2016.06.007_bib42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1078\/0171-9335-00410","article-title":"Neuroligin 2 is exclusively localized to inhibitory synapses","volume":"83","author":"Varoqueaux","year":"2004","journal-title":"Eur. J. Cell Biol."},{"issue":"18","key":"10.1016\/j.euroneuro.2016.06.007_bib43","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/bioinformatics\/bth449","article-title":"limmaGUI: a graphical user interface for linear modeling of microarray data","volume":"20","author":"Wettenhall","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.euroneuro.2016.06.007_bib44","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1073\/pnas.252784499","article-title":"Individuality and variation in gene expression patterns in human blood","volume":"100","author":"Whitney","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.euroneuro.2016.06.007_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20071033","article-title":"Activation and stabilization of human tryptophan hydroxylase 2 by phosphorylation and 14-3-3 binding","volume":"410","author":"Winge","year":"2008","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.euroneuro.2016.06.007_bib46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.pneurobio.2010.04.005","article-title":"The putative neurodegenerative links between depression and Alzheimer\u05f3s disease","volume":"91","author":"Wuwongse","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.euroneuro.2016.06.007_bib47","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev.biochem.76.053105.094237","article-title":"Modulation of the ryanodine receptor and intracellular calcium","volume":"76","author":"Zalk","year":"2007","journal-title":"Annu. Rev. Biochem."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16300918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X16300918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T07:48:21Z","timestamp":1718696901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X16300918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0924977X16300918"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.06.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726580817.793531021","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}